Manzo Pharmaceuticals, Inc.
Manzo Pharmaceuticals, Inc.
Share · US56510D1063 (OTC)
Overview
No Price
Closing Price OTC 08.12.2025: 0,0001 USD
08.12.2025 21:00
Current Prices from Manzo Pharmaceuticals, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
MNZO
USD
08.12.2025 21:00
0,0001 USD
0,00 USD
Company Profile for Manzo Pharmaceuticals, Inc. Share
Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. is based in Milford, Pennsylvania.
Get up to date insights from finAgent about Manzo Pharmaceuticals, Inc.

Company Data

Name Manzo Pharmaceuticals, Inc.
Company Manzo Pharmaceuticals, Inc.
Website https://www.lactofreedom.com
Primary Exchange OTC UTC
ISIN US56510D1063
Asset Class Share
Sector Financial Services
Industry Shell Companies
CEO Kenneth Manzo
Country United States of America
Currency USD
Employees 0,0 T
Address PO Box 107, 18337 Milford
IPO Date 1998-12-31

Ticker Symbols

Name Symbol
Over The Counter MNZO
More Shares
Investors who hold Manzo Pharmaceuticals, Inc. also have the following shares in their portfolio:
SONORO ENERGY LTD
SONORO ENERGY LTD Share
SPECTRA7 MICROSYSTEMS
SPECTRA7 MICROSYSTEMS Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025